B | S.E. | Wald | Df | Significant | Exp(B) | |
---|---|---|---|---|---|---|
Spain | ||||||
Perceived usefulness of ICTS in clinical practice | 0.200 | 0.445 | 0.202 | 1 | 0.653 | 1.222 |
Ease-of-use of ICTS in clinical practice | 0.667 | 0.364 | 3.354 | 1 | 0.067 | 1.948 |
Optimism | −0.498 | 0.437 | 1.302 | 1 | 0.254 | 0.607 |
Propensity to innovate | 0.724 | 0.373 | 3.769 | 1 | 0.052 | 2.062 |
Level of ICT use | 2.661 | 1.077 | 6.103 | 1 | 0.013 | 14.316 |
Constant | 0.724 | 0.373 | 3.769 | 1 | 0.052 | 2.062 |
Chi-square, 24.859; significant, 0.000 | ||||||
Hosmer-Lemeshow test, 19.273; significant, 0.018 | ||||||
Nagelkerke R Square, 0.275 | ||||||
Colombia | ||||||
Perceived usefulness of ICTS in clinical practice | −0.192 | 0.253 | 0.575 | 1 | 0.448 | 0.826 |
Ease-of-use of ICTS in clinical practice | 0.108 | 0.182 | 0.347 | 1 | 0.556 | 1.113 |
Optimism | 0.485 | 0.269 | 3.254 | 1 | 0.071 | 1.624 |
Propensity to innovate | 0.361 | 0.232 | 2.423 | 1 | 0.120 | 1.435 |
Level of ICT use | 1.212 | 0.511 | 5.626 | 1 | 0.018 | 3.360 |
Constant | −2.878 | 0.951 | 9.163 | 1 | 0.002 | 0.056 |
Chi-square, 14.489; significant, 0.013 | ||||||
Hosmer-Lemeshow test, 14.564; significant, 0.045 | ||||||
Nagelkerke R Square, 0.161 | ||||||
Bolivia | ||||||
Perceived usefulness of ICTS in clinical practice | 0.131 | 0.141 | 0.866 | 1 | 0.352 | 1.140 |
Ease-of-use of ICTS in clinical practice | 0.321 | 0.256 | 1.571 | 1 | 0.210 | 1.379 |
Optimism | 0.484 | 0.150 | 10.371 | 1 | 0.001 | 1.622 |
Propensity to innovate | 0.033 | 0.189 | 0.031 | 1 | 0.861 | 1.034 |
Level of ICT use | 2.040 | 1.049 | 3.780 | 1 | 0.052 | 7.689 |
Constant | -2.224 | 1.375 | 2.618 | 1 | 0.106 | 0.108 |
Chi-square, 20.704; significant, 0.000 | ||||||
Hosmer-Lemeshow test, 14.705; significant, 0.072 | ||||||
Nagelkerke R Square, 0.197 |